DrugPatentWatch Database Preview
TIGLUTIK KIT Drug Profile
Email this page to a colleague
See Plans and PricingWhich patents cover Tiglutik Kit, and what generic alternatives are available?
Tiglutik Kit is a drug marketed by Italfarmaco Spa and is included in one NDA. There is one patent protecting this drug.
This drug has twenty-five patent family members in twenty-one countries.
The generic ingredient in TIGLUTIK KIT is riluzole. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the riluzole profile page.
US ANDA Litigation and Generic Entry Outlook for Tiglutik Kit
A generic version of TIGLUTIK KIT was approved as riluzole by IMPAX LABS on January 29th, 2003.
Summary for TIGLUTIK KIT
| International Patents: | 25 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TIGLUTIK KIT at DailyMed |
US Patents and Regulatory Information for TIGLUTIK KIT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Italfarmaco Spa | TIGLUTIK KIT | riluzole | SUSPENSION;ORAL | 209080-001 | Sep 5, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for TIGLUTIK KIT
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2012520254 | Start Trial |
| Spain | 2400349 | Start Trial |
| Peru | 20120649 | Start Trial |
| Russian Federation | 2011141422 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
